ICICI Securities Limited
BSE NSE

Agilus Diagnostics Limited IPO

Mainboard Upcoming
  • IPO Open Date
  • --
  • IPO Close Date
  • --
  • Allotment date
  • --
  • Listing date
  • --
  • Issue Size
  • --
  • Issue Price Band
  • --
  • Lot Size
  • --
  • Minimum Investment
  • --

Disclaimer: IPO details, GMP, subscription figures, and other related information are for informational purposes only and may not always be accurate or up to date. Please verify the latest details from official sources before investing.

About Agilus Diagnostics Limited

Agilus maintains an international presence across the Middle East, Sub-Saharan Africa, the Commonwealth of Independent States, and the South Asian Association for Regional Cooperation (SAARC).

  • Network spans 25 Indian states and 5 union territories, covering over 1,000 towns and cities and more than 532 districts
  • Follows a hub-and-spoke model with one central global reference laboratory in Mumbai, five regional reference laboratories, and 407 other clinical laboratories (pathology and radiology centres)
  • Operates 25 wellness centres, 3 Centres of Excellence, 3,757 customer touch points (patient service centres and collection centres), and over 12,000 pick-up points serving institutional clients

    • International Presence

    Key Performance (FY 2023)

    • Conducted 39.07 million tests
    • Served 16.62 million patients in India and internationally

    Test Portfolio

    The test portfolio consists of over 3,600 routine and specialized diagnostic tests and wellness packages across various medical specialties.

    Customer Segments

    • B2C: Individual patients through walk-in centres, home collection services in over 80 cities, and digital platforms
    • B2B: Institutional customers including physician offices, hospitals, laboratories, radiology centres, corporate employers, insurance companies, public-private partnerships, and clinical research organizations

    Workforce

    As of March 31, 2023, the company had a total of 7,061 employees in India (including 438 doctors, 4,176 technicians and paramedical staff, and 2,447 support staff) and 84 full-time employees located outside India.

    Competitive Strengths

    • Experienced pan-India diagnostics service provider with a diversified presence and a growing network, well positioned to capitalize on expected growth in the Indian diagnostics industry
    • Comprehensive test offerings providing a one-stop solution for diagnostic requirements
    • Advanced information technology platform supported by integrated systems enabling customer-centric initiatives
    • Well-balanced B2C and B2B revenue mix
    • Quality network of accredited laboratories supported by R&D capabilities focused on genomics and next-generation diagnostics
    • Strong parentage and experienced management team with significant industry experience



    Read More

    IPO Subscription Details

    Category Shares Offered Shares Applied Subscription Times (x)
    Updated on N/A

    Grey Market Premium (GMP)

    GMP Date IPO Price GMP Estimated Listing Price Estimated Profit* Last Updated
    Disclaimer: Grey Market Premium (GMP) is an unofficial market indicator provided for informational purposes only. It may change at any time and should not be considered investment advice or a guarantee of listing gains. Please evaluate company fundamentals, financials, valuation, and subscription data, and consult a SEBI-registered financial advisor before making any investment decision.

    Financials of Agilus Diagnostics Limited

    A quick overview of the key financial performance of Agilus Diagnostics Limited.

    Total Assets (₹ Cr)

    Revenue (₹ Cr)

    Profit after Tax (₹ Cr)

    *All values are in Rs. Cr

    Company Financials

    Revenue decreased by 16%, Profit after Tax (PAT) decreased by 79%, Total Assets increased by 6% between FY2022 and FY2023.

    Period Ended FY2021 FY2022 FY2023
    Revenue 1,035.07 1,604.91 1,347.46
    Assets 1,586.31 2,279.96 2,418.74
    Total Income 1,060.69 1,618.35 1,371.10
    Profit After Tax 131.25 554.71 116.64
    EBITDA 244.20 732.40 262.63
    Net Worth 1,169.57 1,724.34 1,803.77
    Reserves & Surplus 1,232.96 1,787.73 1,867.15
    Total Borrowings 1.25 2.25 2.83
    Amount in ₹ Crore

    IPO Lot Size

    IPO lot size details are currently unavailable.

    Key Performance Indicators (KPI)

    KPI Latest
    ROE (%) 6.12
    ROCE (%) 20.17
    Debt / Equity 0.15
    RoNW (%) 6.61
    PAT Margin (%) 8.66
    EBITDA Margin (%) 19.49
    Pre IPO
    Post IPO
    EPS (₹)
    14.87
    -
    P/E (x)
    -
    -
    Promoter Holding (%)
    57.68
    -
    Disclaimer: KPI values are based on information disclosed in the IPO prospectus and are provided for informational purposes only.

    IPO Lead Manager(s)

    Lead Manager Details

    • ICICI Securities Limited

    Lead Manager Details

    • Axis Capital Limited

    Lead Manager Details

    • Citigroup Global Markets India Private Limited

    IPO Registrar

    • Registrar Name
    • KFin Technologies Limited
    • Phone
    • +91 40 6716 2222 / 1800 309 4001
    • Contact Person
    • M. Murali Krishna
    • SEBI Registration Number
    • INR000000221
    • Address
    • Selenium Tower B, Plot No. 31 and 32, Financial District, Nanakramguda, Serilingampally, Hyderabad – 500 032, Telangana, India

    Company Contact Details

    • Company Name
    • Agilus Diagnostics Limited
    • Phone
    • 0124-6261111
    • Contact Person
    • Trapti, Company Secretary and Compliance Officer
    • Corporate Identity Number
    • U74899PB1995PLC045956
    • Address
    • Fortis Hospital, Sector 62, Phase - VIII, Mohali - 160062, Punjab, India
    View All

    Agilus Diagnostics Limited FAQs

    The Agilus Diagnostics Limited IPO is a MAIN IPO with a total issue size of ₹ crores. The IPO price band is fixed at ₹-- to ₹-- per share, and the minimum lot size is --. The Agilus Diagnostics Limited IPO will open on --, and will close on --. KFin Technologies Limited has been appointed as the registrar for the issue. The equity shares are proposed to be listed on BSE, NSE.

    The Agilus Diagnostics Limited IPO opens on -- and closes on --.

    The Agilus Diagnostics Limited IPO lot size is --, and the minimum amount required for application is --.

    You can apply for the Agilus Diagnostics Limited IPO through your bank account using the ASBA facility or via your online trading and Demat account. To apply online, log in to your broker’s platform, select Agilus Diagnostics Limited IPO, enter the number of lots, choose your price within the price band, and submit the application. After submitting, approve the UPI mandate to block the required amount in your bank account. Once the IPO allotment is finalised, shares will be credited to your Demat account if allotted. If not allotted, the blocked amount will be released automatically.

    The Agilus Diagnostics Limited IPO listing date is --.
    Chat
    Investkraft Assistant Beta Version
    Powered by AI
    👋 Hi! Before we start, may I know your name?
    Scroll Top ↑
    WhatsApp
    Subcribe - Investkraft Newsletter

    Subscribe to our newsletter